Cargando…
Guillain-Barré Syndrome Surveillance during National Influenza Vaccination Campaign, New York, USA, 2009
The New York State Department of Health (NYSDOH) collected information about hospitalized patients with Guillain-Barré syndrome (GBS) during October 2009–May 2010, statewide (excluding New York City), to examine a possible relationship with influenza A(H1N1)pdm09 vaccination. NYSDOH established a Cl...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3840872/ https://www.ncbi.nlm.nih.gov/pubmed/24274387 http://dx.doi.org/10.3201/eid1912.130643 |
_version_ | 1782478574495727616 |
---|---|
author | Giambrone, Gregory P. Zansky, Shelley M. Eidson, Millicent Duncan, Pamela G. McNutt, Louise-Anne Birkhead, Guthrie S. |
author_facet | Giambrone, Gregory P. Zansky, Shelley M. Eidson, Millicent Duncan, Pamela G. McNutt, Louise-Anne Birkhead, Guthrie S. |
author_sort | Giambrone, Gregory P. |
collection | PubMed |
description | The New York State Department of Health (NYSDOH) collected information about hospitalized patients with Guillain-Barré syndrome (GBS) during October 2009–May 2010, statewide (excluding New York City), to examine a possible relationship with influenza A(H1N1)pdm09 vaccination. NYSDOH established a Clinical Network of neurologists and 150 hospital neurology units. Hospital discharge data from the Statewide Planning and Research Cooperative System (SPARCS) were used to evaluate completeness of reporting from the Clinical Network. A total of 140 confirmed or probable GBS cases were identified: 81 (58%) from both systems, 10 (7%) from Clinical Network only, and 49 (35%) from SPARCS-only. Capture–recapture methods estimated that 6 cases might have been missed by both systems. Clinical Network median reporting time was 12 days versus 131 days for SPARCS. In public health emergencies in New York State, a Clinical Network may provide timely data, but in our study such data were less complete than traditional hospital discharge data. |
format | Online Article Text |
id | pubmed-3840872 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Centers for Disease Control and Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-38408722013-12-04 Guillain-Barré Syndrome Surveillance during National Influenza Vaccination Campaign, New York, USA, 2009 Giambrone, Gregory P. Zansky, Shelley M. Eidson, Millicent Duncan, Pamela G. McNutt, Louise-Anne Birkhead, Guthrie S. Emerg Infect Dis Research The New York State Department of Health (NYSDOH) collected information about hospitalized patients with Guillain-Barré syndrome (GBS) during October 2009–May 2010, statewide (excluding New York City), to examine a possible relationship with influenza A(H1N1)pdm09 vaccination. NYSDOH established a Clinical Network of neurologists and 150 hospital neurology units. Hospital discharge data from the Statewide Planning and Research Cooperative System (SPARCS) were used to evaluate completeness of reporting from the Clinical Network. A total of 140 confirmed or probable GBS cases were identified: 81 (58%) from both systems, 10 (7%) from Clinical Network only, and 49 (35%) from SPARCS-only. Capture–recapture methods estimated that 6 cases might have been missed by both systems. Clinical Network median reporting time was 12 days versus 131 days for SPARCS. In public health emergencies in New York State, a Clinical Network may provide timely data, but in our study such data were less complete than traditional hospital discharge data. Centers for Disease Control and Prevention 2013-12 /pmc/articles/PMC3840872/ /pubmed/24274387 http://dx.doi.org/10.3201/eid1912.130643 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited. |
spellingShingle | Research Giambrone, Gregory P. Zansky, Shelley M. Eidson, Millicent Duncan, Pamela G. McNutt, Louise-Anne Birkhead, Guthrie S. Guillain-Barré Syndrome Surveillance during National Influenza Vaccination Campaign, New York, USA, 2009 |
title | Guillain-Barré Syndrome Surveillance during National Influenza Vaccination Campaign, New York, USA, 2009 |
title_full | Guillain-Barré Syndrome Surveillance during National Influenza Vaccination Campaign, New York, USA, 2009 |
title_fullStr | Guillain-Barré Syndrome Surveillance during National Influenza Vaccination Campaign, New York, USA, 2009 |
title_full_unstemmed | Guillain-Barré Syndrome Surveillance during National Influenza Vaccination Campaign, New York, USA, 2009 |
title_short | Guillain-Barré Syndrome Surveillance during National Influenza Vaccination Campaign, New York, USA, 2009 |
title_sort | guillain-barré syndrome surveillance during national influenza vaccination campaign, new york, usa, 2009 |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3840872/ https://www.ncbi.nlm.nih.gov/pubmed/24274387 http://dx.doi.org/10.3201/eid1912.130643 |
work_keys_str_mv | AT giambronegregoryp guillainbarresyndromesurveillanceduringnationalinfluenzavaccinationcampaignnewyorkusa2009 AT zanskyshelleym guillainbarresyndromesurveillanceduringnationalinfluenzavaccinationcampaignnewyorkusa2009 AT eidsonmillicent guillainbarresyndromesurveillanceduringnationalinfluenzavaccinationcampaignnewyorkusa2009 AT duncanpamelag guillainbarresyndromesurveillanceduringnationalinfluenzavaccinationcampaignnewyorkusa2009 AT mcnuttlouiseanne guillainbarresyndromesurveillanceduringnationalinfluenzavaccinationcampaignnewyorkusa2009 AT birkheadguthries guillainbarresyndromesurveillanceduringnationalinfluenzavaccinationcampaignnewyorkusa2009 |